Divalproex Sodium Delayed-release Tablets USP recall
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem…
Why was Divalproex Sodium Delayed-release Tablets USP recalled?
Failed Tablet/Capsule Specifications
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 02D163, Exp. 9/2017
- Product
- Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem…
- Recalling firm
- Teva North America
- Quantity
- 14, 370 units
- Distribution
- Nationwide and Puerto Rico
- Recall date
- August 3, 2016
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)